Over the five years to 2017, Health and Medical Reinsurance industry revenue has grown along with healthcare coverage as primary insurers used reinsurers to manage risk and increase their underwriting capacity. Moreover, rising stock market values have helped bolster investment income in recent years. Over the five years to 2022, to reach rising demand, industry operators will continue to expand their capacity and pursue alternative reinsurance structures. In addition, reinsurers will look to diversify product portfolios to mitigate fluctuations in any particular reinsurance line. Industry operators will likely also use reserves to stabilize their bottom lines, enabling them to achieve stronger credit ratings and receive more favorable treatment from capital markets.
This industry includes companies that assume risks originally underwritten by health and medical insurers.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.